Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How can the European Society of Cardiology ensure compliance with ethical standards?
Simoons ML, Bassand JP, Bax J, Bertrand M, Breithardt G, Ferrari R, Fox K, Hugenholtz P, Komajda M, Pinto F, Rydén L, Tendera M, Vardas P. Simoons ML, et al. Among authors: bertrand m. Eur Heart J. 2016 Mar 1;37(9):741-4. doi: 10.1093/eurheartj/ehv651. Epub 2015 Dec 18. Eur Heart J. 2016. PMID: 26685144 No abstract available.
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
Brugts JJ, Ninomiya T, Boersma E, Remme WJ, Bertrand M, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons ML. Brugts JJ, et al. Among authors: bertrand m. Eur Heart J. 2009 Jun;30(11):1385-94. doi: 10.1093/eurheartj/ehp103. Epub 2009 Apr 4. Eur Heart J. 2009. PMID: 19346520 Free article.
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.
Brugts JJ, Isaacs A, Boersma E, van Duijn CM, Uitterlinden AG, Remme W, Bertrand M, Ninomiya T, Ceconi C, Chalmers J, MacMahon S, Fox K, Ferrari R, Witteman JC, Danser AH, Simoons ML, de Maat MP. Brugts JJ, et al. Among authors: bertrand m. Eur Heart J. 2010 Aug;31(15):1854-64. doi: 10.1093/eurheartj/ehq169. Epub 2010 Jun 10. Eur Heart J. 2010. PMID: 20538738 Clinical Trial.
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients.
van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E. van Vark LC, et al. Among authors: bertrand m. Eur Heart J. 2012 Aug;33(16):2088-97. doi: 10.1093/eurheartj/ehs075. Epub 2012 Apr 17. Eur Heart J. 2012. PMID: 22511654 Free PMC article. Review.
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.
Brugts JJ, Boersma E, Chonchol M, Deckers JW, Bertrand M, Remme WJ, Ferrari R, Fox K, Simoons ML; EUROPA Investigators. Brugts JJ, et al. Among authors: bertrand m. J Am Coll Cardiol. 2007 Nov 27;50(22):2148-55. doi: 10.1016/j.jacc.2007.08.029. Epub 2007 Nov 13. J Am Coll Cardiol. 2007. PMID: 18036453 Free article. Clinical Trial.
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease.
Battes L, Barendse R, Steyerberg EW, Simoons ML, Deckers JW, Nieboer D, Bertrand M, Ferrari R, Remme WJ, Fox K, Takkenberg JJ, Boersma E, Kardys I. Battes L, et al. Among authors: bertrand m. Am J Cardiol. 2013 Jul 1;112(1):27-33. doi: 10.1016/j.amjcard.2013.02.049. Epub 2013 Apr 1. Am J Cardiol. 2013. PMID: 23558041 Clinical Trial.
Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study).
Rodriguez-Granillo GA, Vos J, Bruining N, Garcia-Garcia HM, de Winter S, Ligthart JM, Deckers JW, Bertrand M, Simoons ML, Ferrari R, Fox KM, Remme W, De Feyter PJ; Investigators of the EUROPA Study. Rodriguez-Granillo GA, et al. Among authors: bertrand m. Am J Cardiol. 2007 Jul 15;100(2):159-63. doi: 10.1016/j.amjcard.2007.02.073. Epub 2007 May 30. Am J Cardiol. 2007. PMID: 17631061 Clinical Trial.
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals.
Brugts JJ, Isaacs A, de Maat MP, Boersma E, van Duijn CM, Akkerhuis KM, Uitterlinden AG, Witteman JC, Cambien F, Ceconi C, Remme W, Bertrand M, Ninomiya T, Harrap S, Chalmers J, Macmahon S, Fox K, Ferrari R, Simoons ML, Danser AJ. Brugts JJ, et al. Among authors: bertrand m. J Hypertens. 2011 Mar;29(3):509-19. doi: 10.1097/HJH.0b013e328341d117. J Hypertens. 2011. PMID: 21157371
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA.
van der Leeuw J, Oemrawsingh RM, van der Graaf Y, Brugts JJ, Deckers JW, Bertrand M, Fox K, Ferrari R, Remme WJ, Simoons ML, Boersma E, Visseren FL. van der Leeuw J, et al. Among authors: bertrand m. Int J Cardiol. 2015 Mar 1;182:194-9. doi: 10.1016/j.ijcard.2014.12.046. Epub 2014 Dec 23. Int J Cardiol. 2015. PMID: 25577762 Free article. Clinical Trial.
1,456 results